Acquisitions - Expenses (Details) - VectivBio Holding AG and its subsidiaries - USD ($) $ in Millions	12 Months Ended
Dec. 31, 2024	Dec. 31, 2023
Acquisitions
Asset acquisition, acquisition related costs	$ 3.6	$ 55.6
Selling, General and Administrative Expenses
Acquisitions
Asset acquisition, acquisition related costs	1.1	25.6
Research and Development Expense
Acquisitions
Asset acquisition, acquisition related costs		15.1
Restructuring Charges
Acquisitions
Asset acquisition, acquisition related costs	$ 2.5	$ 14.9

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 15
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480123/805-50-15-3

Name:	us-gaap_AssetAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration